Sofinnova Investments as of March 31, 2019
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 67 positions in its portfolio as reported in the March 2019 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ascendis Pharma A S (ASND) | 11.3 | $118M | 999k | 117.70 | |
Amarin Corporation (AMRN) | 10.4 | $108M | 5.2M | 20.76 | |
Principia Biopharma | 6.7 | $69M | 2.0M | 34.00 | |
Natera (NTRA) | 6.2 | $64M | 3.1M | 20.62 | |
Obseva Sa | 5.9 | $61M | 4.7M | 12.79 | |
Y Mabs Therapeutics (YMAB) | 5.3 | $55M | 2.1M | 26.21 | |
Spark Therapeutics | 5.3 | $55M | 481k | 113.88 | |
Nucana Biomed ordinary shares | 3.9 | $41M | 2.4M | 17.00 | |
Coherus Biosciences (CHRS) | 3.8 | $39M | 2.9M | 13.64 | |
Nucana Plc american depositary shares (NCNA) | 3.7 | $39M | 2.3M | 17.00 | |
Audentes Therapeutics | 3.5 | $36M | 934k | 39.02 | |
Merus N V (MRUS) | 2.8 | $29M | 2.0M | 14.77 | |
Ishares Tr Index option | 2.6 | $27M | 242k | 111.79 | |
Kiniksa Pharmaceuticals (KNSA) | 1.6 | $17M | 923k | 18.06 | |
Iterum Therapeutics | 1.3 | $14M | 1.7M | 7.92 | |
Novo Nordisk A/S (NVO) | 1.2 | $13M | 248k | 52.31 | |
Allergan | 1.2 | $13M | 89k | 146.40 | |
Abbvie (ABBV) | 1.2 | $12M | 150k | 80.59 | |
Aclaris Therapeutics (ACRS) | 1.1 | $12M | 1.9M | 5.99 | |
AstraZeneca (AZN) | 1.0 | $11M | 262k | 40.42 | |
Alnylam Pharmaceuticals (ALNY) | 1.0 | $10M | 107k | 93.46 | |
Neurocrine Biosciences (NBIX) | 0.9 | $9.9M | 112k | 88.12 | |
Biogen Idec (BIIB) | 0.9 | $9.5M | 40k | 236.33 | |
Macrogenics (MGNX) | 0.9 | $9.4M | 524k | 17.98 | |
Chiasma | 0.8 | $8.5M | 1.6M | 5.20 | |
Amicus Therapeutics (FOLD) | 0.8 | $7.9M | 584k | 13.60 | |
Entasis Therapeutics Holdings Ord | 0.8 | $8.0M | 1.2M | 6.75 | |
Anaptysbio Inc Common (ANAB) | 0.7 | $7.2M | 98k | 73.03 | |
Xencor (XNCR) | 0.6 | $6.5M | 210k | 31.05 | |
Dermira | 0.6 | $6.6M | 484k | 13.55 | |
Halozyme Therapeutics (HALO) | 0.6 | $6.5M | 401k | 16.10 | |
Biohaven Pharmaceutical Holding | 0.6 | $6.4M | 125k | 51.48 | |
Morphosys (MPSYF) | 0.6 | $6.3M | 69k | 91.01 | |
Heron Therapeutics (HRTX) | 0.6 | $5.7M | 234k | 24.43 | |
Blueprint Medicines (BPMC) | 0.6 | $5.8M | 72k | 80.03 | |
Reata Pharmaceuticals Inc Cl A | 0.5 | $5.6M | 65k | 85.51 | |
Savara (SVRA) | 0.5 | $5.7M | 767k | 7.37 | |
Intercept Pharmaceuticals In | 0.5 | $5.0M | 45k | 111.82 | |
Deciphera Pharmaceuticals (DCPH) | 0.5 | $5.0M | 215k | 23.21 | |
Orchard Therapeutics Plc ads | 0.5 | $4.9M | 276k | 17.89 | |
Incyte Corporation (INCY) | 0.4 | $4.6M | 53k | 86.06 | |
Kadmon Hldgs | 0.4 | $4.4M | 1.7M | 2.64 | |
Synlogic | 0.4 | $4.4M | 575k | 7.59 | |
Akebia Therapeutics (AKBA) | 0.4 | $4.2M | 517k | 8.19 | |
Insmed (INSM) | 0.4 | $4.1M | 140k | 29.08 | |
Puma Biotechnology (PBYI) | 0.3 | $3.6M | 94k | 38.79 | |
Fate Therapeutics (FATE) | 0.3 | $3.6M | 204k | 17.58 | |
Gw Pharmaceuticals Plc ads | 0.3 | $3.4M | 20k | 168.48 | |
Fibrogen (FGEN) | 0.3 | $3.2M | 59k | 54.36 | |
Foamix Pharmaceuticals | 0.3 | $3.1M | 832k | 3.75 | |
Xbiotech (XBIT) | 0.3 | $2.9M | 261k | 11.01 | |
Kala Pharmaceuticals | 0.3 | $2.9M | 345k | 8.27 | |
Tg Therapeutics (TGTX) | 0.3 | $2.8M | 352k | 8.05 | |
Otonomy | 0.3 | $2.7M | 1.0M | 2.63 | |
Fibrogen | 0.3 | $2.7M | 50k | 54.40 | |
Galapagos Nv- (GLPG) | 0.2 | $2.4M | 20k | 117.67 | |
BioMarin Pharmaceutical (BMRN) | 0.2 | $1.6M | 19k | 88.70 | |
ArQule | 0.2 | $1.7M | 356k | 4.79 | |
Clovis Oncology | 0.2 | $1.7M | 67k | 24.81 | |
Syndax Pharmaceuticals (SNDX) | 0.1 | $1.1M | 213k | 5.26 | |
Portola Pharmaceuticals | 0.1 | $1.0M | 30k | 34.71 | |
Pds Biotechnology Ord (PDSB) | 0.1 | $1.1M | 143k | 7.40 | |
Apellis Pharmaceuticals (APLS) | 0.1 | $967k | 50k | 19.50 | |
Osmotica Pharmaceuticals (RVLPQ) | 0.1 | $911k | 253k | 3.60 | |
Adverum Biotechnologies | 0.1 | $838k | 159k | 5.26 | |
ImmunoGen | 0.0 | $405k | 150k | 2.70 | |
Conatus Pharmaceuticals | 0.0 | $161k | 150k | 1.07 |